Beligas Pharmaceuticals is a Belgium pharmaceutical company that focuses on the development of human growth hormone, anabolic steroids (oral, raw steroid powders, injectables, and other products), and peptides. Through the years, we have proven our place in the pan-European market and is actively steering our way to the worldwide pharmaceutical sector.
We successfully concluded the phase 1 of a clinical trial for the first growth hormone frag 191+ in Europe in the year 2014. This placed Beligas on top of the top-tier biosimilar developers. Anabolic steroids are man-made or synthetic variations of testosterone, the male sex hormone. This aims to help people who are working to build more muscles and have an increased male characteristics. Unlike cheap and unreliable products in the market, our products are made from the most reliable ingredients and using the best practices in the industry.
